Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
Clinical trial NCT01321437 · COMPLETED
Trial details
- NCT number
- NCT01321437
- Sponsor
- University of California, Irvine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2016-12-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.